Consolidated Balance Sheets (Unaudited) - USD ($) $ in Millions	Dec. 31, 2023	Mar. 31, 2023
Assets
Cash and cash equivalents	$ 1,439	$ 1,544
Finance receivables, net of allowance for credit losses of $343 and $253	45,535	37,585
Investment in operating leases, net	27,246	27,778
Income taxes receivable	24	28
Other assets	1,102	757
Derivative instruments	842	1,133
Total assets	76,317	68,891
Liabilities and Equity
Debt	47,904	40,334
Income taxes payable	355	211
Deferred income taxes	5,802	6,287
Derivative instruments	1,393	1,736
Total liabilities	57,373	49,866
Commitments and contingencies (Note 8)
Shareholder’s equity:
Common stock, $100 par value. Authorized 15,000,000 shares; issued and outstanding 13,660,000 shares as of December 31, 2023 and March 31, 2023	1,366	1,366
Retained earnings	16,543	16,688
Accumulated other comprehensive loss	(110)	(135)
Total shareholder’s equity	17,799	17,919
Noncontrolling interest in subsidiary	1,145	1,106
Total equity	18,944	19,025
Total liabilities and equity	76,317	68,891
Variable Interest Entity, Primary Beneficiary
Assets
Finance receivables, net of allowance for credit losses of $343 and $253	9,189	7,216
Investment in operating leases, net	0	168
Other assets	692	433
Total assets	9,881	7,817
Liabilities and Equity
Debt	8,722	6,927
Due to Parent and affiliated companies and Other liabilities	14	7
Total liabilities	8,736	6,934
Nonrelated Party and Affiliated Entity
Liabilities and Equity
Due to Parent and affiliated companies and Other liabilities	1,788	1,137
Affiliated Entity
Assets
Due from Parent and affiliated companies	129	66
Liabilities and Equity
Due to Parent and affiliated companies and Other liabilities	$ 131	$ 161